Detalhe da pesquisa
1.
Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria Transmission.
J Infect Dis
; 228(2): 212-223, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37042518
2.
Mass campaigns combining antimalarial drugs and anti-infective vaccines as seasonal interventions for malaria control, elimination and prevention of resurgence: a modelling study.
BMC Infect Dis
; 19(1): 920, 2019 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31664924
3.
Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates.
Malar J
; 15(1): 405, 2016 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27515826
4.
The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants.
Malar J
; 14: 72, 2015 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25885325
5.
Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP.
NPJ Vaccines
; 3: 49, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323956
6.
The frontline of controlled human malaria infections: A report from the controlled human infection models Workshop in Leiden University Medical Centre 5 May 2016.
Vaccine
; 35(51): 7065-7069, 2017 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29153778
7.
Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge.
PLoS One
; 9(11): e109654, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25405724
8.
Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
PLoS One
; 4(11): e7849, 2009 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19924281
9.
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
Vaccine
; 25(21): 4203-12, 2007 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-17442466
10.
Advances in immunology and vaccine discovery report of the United States-European Commission workshop.
Vaccine
; 25(41): 7007-11, 2007 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-17728022
11.
Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.
Vaccine
; 22(13-14): 1592-603, 2004 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-15068840